Compare · AONC vs PRVA
AONC vs PRVA
Side-by-side comparison of American Oncology Network Inc. (AONC) and Privia Health Group Inc. (PRVA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AONC and PRVA operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- PRVA carries a market cap of $3.21B.
- PRVA has hit the wire 9 times in the past 4 weeks while AONC has been quiet.
- PRVA has more recent analyst coverage (25 ratings vs 0 for AONC).
- Company
- American Oncology Network Inc.
- Privia Health Group Inc.
- Price
- $2.25+25.00%
- $25.50+2.16%
- Market cap
- -
- $3.21B
- 1M return
- -
- +4.04%
- 1Y return
- -
- +29.28%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 0
- 9
- Recent ratings
- 0
- 25
Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
Latest AONC
- SEC Form 10-K filed by American Oncology Network Inc.
- Cancer and Blood Specialists of Arizona and American Oncology Network Welcome Dr. Ronak Rakesh Shah
- SEC Form 15-15D filed by American Oncology Network Inc.
- Hematology Oncology of Indiana Physician Research Presented at 66th ASH Annual Meeting
- Amendment: American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- American Oncology Network's Specialty Pharmacy Achieves ACHC Reaccreditation
- SEC Form EFFECT filed by American Oncology Network Inc.
- SEC Form S-8 POS filed by American Oncology Network Inc.
- SEC Form POS AM filed by American Oncology Network Inc.
Latest PRVA
- EVP & Chief Financial Officer Mountcastle David sold $588,679 worth of shares (21,275 units at $27.67) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 164,853 units (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David sold $16,542 worth of shares (600 units at $27.57) as part of a pre-agreed trading plan, decreasing direct ownership by 0.32% to 186,128 units (SEC Form 4)
- Privia Health Group Inc. filed SEC Form 8-K: Leadership Update
- Director Morris Matthew Shawn exercised 112,759 shares at a strike of $2.00 and sold $3,076,868 worth of shares (112,759 units at $27.29) as part of a pre-agreed trading plan, decreasing direct ownership by 11% to 68,188 units (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David sold $680,185 worth of shares (24,734 units at $27.50) as part of a pre-agreed trading plan, decreasing direct ownership by 12% to 186,728 units (SEC Form 4)
- Privia Health to Report Second Quarter 2026 Results on Thursday, August 6
- Director Morris Matthew Shawn exercised 135,498 shares at a strike of $2.00 and sold $3,566,335 worth of shares (135,498 units at $26.32) as part of a pre-agreed trading plan (SEC Form 4)
- Director Morris Matthew Shawn exercised 151,322 shares at a strike of $2.00 and sold $3,832,986 worth of shares (151,322 units at $25.33) as part of a pre-agreed trading plan (SEC Form 4)
- EVP & Chief Financial Officer Mountcastle David exercised 17,196 shares at a strike of $2.00 and sold $432,995 worth of shares (17,196 units at $25.18) as part of a pre-agreed trading plan (SEC Form 4)
- Privia Health Enters New Jersey